T. Guney (London, United Kingdom), F. Blasi (Milan, Italy), E. Márquez Martín (Sevilla, Spain)
Prevotella genera abundance in bronchial brush samples differentiates COPD from health and is associated with gene expression
M. Yavari Ramsheh (Leicester, United Kingdom), G. Thun (Barcelona, Spain), A. Esteve Codina (Barcelona, Spain), K. Haldar (Leicester, United Kingdom), M. Barer (Leicester, United Kingdom), I. Gut (Barcelona, Spain), L. Ziegler-Heitbrock (Gauting, Germany), D. Singh (Manchester, United Kingdom), C. Brightling (Leicester, United Kingdom)
|   |
Clinical significance of serum MRGPRX2 as a new biomarker in allergic asthma
J. An (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), Y. Kang (Seoul, Republic of Korea), H. Won (Seoul, Republic of Korea), W. Song (Seoul, Republic of Korea), H. Kwon (Seoul, Republic of Korea), Y. Cho (Seoul, Republic of Korea), H. Moon (Seoul, Republic of Korea), T. Kim (Seoul, Republic of Korea)
| |
Relationship between level of transforming growth factor beta 1 (TGF beta 1) and serum amyloid A in COPD patients
D. Koval (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine)
| |
How does smoking influence major phospholipids and proteins in lung surfactant?
J. Kim (Gothenburg, Sweden), H. Koca (Gothenburg, Sweden), E. Viklund (Gothenburg, Sweden), A. Olin (Gothenburg, Sweden)
| |
Nasal cytology analysis in stable COPD patients
M. Vulpi (Bari, Italy), M. Dimitri (Bari, Italy), E. Buonamico (Bari, Italy), V. Quaranta (Bari, Italy), B. Sterlicchio (Bari, Italy), V. Liotino (Bari, Italy), M. Gelardi (Bari, Italy), O. Resta (Bari, Italy)
| |
Altered phenotype of COPD primary fibroblasts from airway and alveolar tissues: proliferation and apoptosis.
Y. Zeng (Shanghai, China), W. Hu (Shanghai, China), Y. Zuo (Shanghai, China), J. Zhang (Shanghai, China)
| |
Modelling electronic nose sensor deflections by matching Gas Chromatography-Mass Spectrometry exhaled breath samples
P. Brinkman (Amsterdam, Netherlands), A. Sinha (Amsterdam, Netherlands), A. Lammers (Amsterdam, Netherlands), J. Van Bragt (Amsterdam, Netherlands), L. Richards (Amsterdam, Netherlands), Y. Dagelet (Amsterdam, Netherlands), M. Ibrahim (Amsterdam, Netherlands), A. Neerincx (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands), P. Sterk (Amsterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands)
| |
Correlation between the asthma control, bronchial inflammation and airway response to hypoosmotic stimulus
J. Perelman (Blagoveshchensk, Russian Federation), E. Borodin (Blagoveshchensk, Russian Federation), M. Shtarberg (Blagoveshchensk, Russian Federation), A. Prikhodko (Blagoveshchensk, Russian Federation), E. Afanaseva (Blagoveshchensk, Russian Federation), V. Pavlenko (Blagoveshchensk, Russian Federation), N. Grigoryev (Blagoveshchensk, Russian Federation)
| |
Assessment of induced sputum cellularity in COPD patients belonging to two different classes of air pollution exposure.
S. Dragonieri (bari, Italy), D. Lacedonia (foggia, Italy), G. Palladino (foggia, Italy), G. Scioscia (foggia, Italy), G. Carpagnano (foggia, Italy), P. Carratu (bari, Italy), O. Resta (bari, Italy), M. Foschino Barbaro (foggia , Italy)
| |
The role of inflammatory biomarkers like precursors of COPD stability during long-term follow-up
B. Basina (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine)
| |
Multi-matrices screening for untargeted volatilomics by GC×GC-TOFMS
D. Zanella (Liege, Belgium), P. Stefanuto (Liege, Belgium), F. Schleich (Liege, Belgium), R. Louis (Liege, Belgium), J. Focant (Liege, Belgium)
| |
Surfactant Protein A in Particles in Exhaled Air and serum
H. Koca Akdeve (Gothenburg, Sweden)
| |
Blood neutrophils correlate with obesity in asmatic patients
M. Lampalo (Zagreb, Croatia), N. Ferara (Zagreb, Croatia), I. Jukic (Zagreb, Croatia), A. Štajduhar (Zagreb, Croatia), B. Barišic (Zagreb, Croatia), M. Samaržija (Zagreb, Croatia), S. Popovic Grle (Zagreb, Croatia)
| |
Artificial neural networks within the severity stratification of the chronic obstructive pulmonary disease
B. Geltser (Vladivostok, Russian Federation), ?. Shahgeldyan (Vladivostok, Russian Federation), I. Kurpatov (Vladivostok, Russian Federation), V. Kotelnikov (Vladivostok, Russian Federation)
| |
Expiratory gas analysis using mass spectrometry in chronic obstructive pulmonary disease
N. Kawata (Chiba, Japan), T. Sugiura (Chiba, Japan), Y. Matsuura (Chiba, Japan), J. Ikari (Chiba, Japan), E. Suzuki (Chiba, Japan), M. Abe (Chiba, Japan), Y. Tada (Chiba, Japan), N. Sakurai (kisarazuChiba, Japan), K. Tatsumi (Chiba, Japan)
| |
Automated cell differential count in sputum is feasible and comparable to manual cell count in identifying eosinophilia
L. Frøssing (Copenhagen, Denmark), T. Hartvig Lindkær Jensen (Copenhagen, Denmark), J. Østrup Nielsen (Copenhagen, Denmark), D. Parker (Leicester, United Kingdom), C. Porsbjerg (Copenhagen, Denmark), V. Backer (Copenhagen, Denmark)
| |
Late Breaking Abstract - Diagnosis of chronic obstructive pulmonary disease (COPD) exacerbations using a smartphone-based, cough-centred algorithm
P. Porter (Perth, Australia), S. Claxton (Perth, Australia), J. Wood (Brisbane, Australia), V. Peltonen (Brisbane, Australia), J. Brisbane (Perth, Australia), F. Purdie (Perth, Australia), C. Smith (Perth, Australia), N. Bear (Perth, Australia), U. Abeyratne (Brisbane, Australia)
| |
Regulation disorders of pulmonary lipid metabolism in chronic obstructive pulmonary disease
S. Kotlyarov (Ryazan, Russian Federation), A. Bulgakov (Ryazan, Russian Federation)
| |
Particles in exhaled air before and after the methacholine challenge test
E. Ternsten (Gothenburg, Sweden), E. Johansson (gothenburg, Sweden), S. Kokelj (Gothenburg, Sweden), H. Krage Carlsen (Gothenburg, Sweden), E. Millquist (Gothenburg, Sweden), A. Olin (Gothenburg, Sweden)
| |